Form 4: Edwards Lifesciences Officer Sells Shares

Edwards Lifesciences CVP Wayne Markowitz reported the sale of 583 common shares for $86.01 each under a pre-arranged trading plan.

Summary

• Wayne Markowitz, CVP, JAPAC at Edwards Lifesciences Corp (EW), sold 583 shares of common stock.
• The transaction occurred on December 8, 2025.
• The shares were sold at a price of $86.01 per share.
• Following this transaction, Mr. Markowitz directly owns 17,562.8708 shares of Edwards Lifesciences common stock.
• The sale was executed pursuant to a Rule 10b5-1(c) trading plan.

Sentiment

Score: 5

Explanation: Neutral. A routine insider sale, especially under a 10b5-1 plan, is generally considered a neutral event. It reflects personal financial planning rather than a statement on the company's prospects.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing and does not provide specific industry context. Edwards Lifesciences operates in the medical technology sector, specializing in heart valves and hemodynamic monitoring.

Related Party Transactions

• Wayne Markowitz, an officer of Edwards Lifesciences Corp, sold 583 shares of the company's common stock.

Stakeholder Impact

• Shareholders: The sale by an officer could be interpreted by some as a minor signal, though its execution under a 10b5-1 plan mitigates concerns about its implications for future performance.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Key Dates

Keywords

Edwards Lifesciences, EW, Insider Sale, Form 4, Wayne Markowitz, Stock Transaction, 10b5-1 Plan